sitagavia 50 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagavia 25 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin krka 25 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
maysiglu 100 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
maysiglu 50 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
maysiglu 25 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin tad 100 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin tad 50 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin tad 25 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritída, reumatoidná artritída - imunosupresíva - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.